The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Serum amyloid A opposes lipoxin A 4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) will soon be the third most common cause of death globally. Despite smoking cessation, neutrophilic mucosal inflammation persistently damages the airways and fails to protect from recurrent infections. This maladaptive and excess inflammation is also refractory to glucocorticosteroids (GC). Here, we identify serum amyloid A (SAA) as a candidate mediator of GC refractory inflammation in COPD. Extrahepatic SAA was detected locally in COPD bronchoalveolar lavage fluid, which correlated with IL-8 and neutrophil elastase, consistent with neutrophil recruitment and activation. Immunohistochemistry detected SAA was in close proximity to airway epithelium, and in vitro SAA triggered release of IL-8 and other proinflammatory mediators by airway epithelial cells in an ALX/FPR2 (formyl peptide receptor 2) receptor-dependent manner. Lipoxin A 4 (LXA 4 ) can also interact with ALX/FPR2 receptors and lead to allosteric inhibition of SAA-initiated epithelial responses (pA 2 13 nM). During acute exacerbation, peripheral blood SAA levels increased dramatically and were disproportionately increased relative to LXA 4 . Human lung macrophages (CD68 + ) colocalized with SAA and GCs markedly increased SAA in vitro (THP-1, pEC 50 43 nM). To determine its direct actions, SAA was administered into murine lung, leading to induction of CXC chemokine ligand 1/2 and a neutrophilic response that was inhibited by 15-epi-LXA 4 but not dexamethasone. Taken together, these findings identify SAA as a therapeutic target for inhibition and implicate SAA as a mediator of GC-resistant lung inflammation that can overwhelm organ protective signaling by lipoxins at ALX/FPR2 receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent article reported that the increase in the serum level of serum amyloid A (SAA) is associated with glucocorticoid resistance [6].”
From Picroside II Isolated from Pseudolysimachion rotundum var. subintegrum Inhibits Glucocorticoid Refractory Serum Amyloid A (SAA) Expression and SAA-induced IL-33 Secretion (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has been shown that DEX induces SAA expression on its own and synergistically increases LPS-induced SAA expression in THP-1 cells [6].”
The cited source says what the claim attributes to it.
In the citing paper
“It has been shown that SAA/IL-33 play a role in the pathology of steroid-resistant lung inflammation [6,15].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Burden and clinical features of chronic obstructive pulmonary disease (COPD)
PAUWELS, R. A., & Rabe, K. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16855-4 · Cited by 1,015
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Effects of cigarette smoke on the human airway epithelial cell transcriptome
Spira, A. E., Beane, J., Shah, V., Liu, G., Schembri, F. M., Yang, X., Palma, J. F., & Brody, J. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401422101 · Cited by 622
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 449
Su, S. B., Gong, W., Gao, J., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.395 · Cited by 430
Hurst, J. R., Perera, W. R., Wilkinson, T. M. A., Donaldson, G. C., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-704oc · Cited by 346
Culpitt, S. V., Rogers, D. F., Shah, P. L., de Matos, C., Russell, R. E. K., Donnelly, L., & Barnes, P. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-298oc · Cited by 337
Cited by
Sorted by citations
Items 101–163 of 163
A signaling network map of Lipoxin (LXA4): an anti-inflammatory molecule
Suchitha, G. P., Balaya, R. D. A., Prasad, T. S. K., & Dagamajalu, S. (2024) · Inflammation Research · doi:10.1007/s00011-024-01885-6 · Cited by 23
Lütfioğlu, M., Aydoğdu, A., Sakallıoğlu, E. E., Alaçam, H., & Pamuk, F. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12324 · Cited by 23
Wang, C., & Baker, O. J. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.04.003 · Cited by 23
Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands
Salama, S. A., Gouwy, M., Damme, J. V., & Struyf, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1119227 · Cited by 22
Planagumà, A., Domènech, T., Jover, I., Ramos, I., Sentellas, S., Malhotra, R., & Miralpeix, M. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12110 · Cited by 22
Flayer, C. H., Ge, M. Q., Hwang, J. W., Kokalari, B., Redai, I. G., Jiang, Z., & Haczku, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02173 · Cited by 22
Glucocorticoids and Toll-like receptor 2 cooperatively induce acute-phase serum amyloid A
Su, Q., & Weindl, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.012 · Cited by 21
Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2
Chen, K., Gong, W., Huang, J., Yoshimura, T., & Wang, J. M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110052 · Cited by 20
Vannitamby, A., Saad, M. I., Aloe, C. A., Wang, H., Kumar, B., Vlahos, R., Selemidis, S., Irving, L. B., Steinfort, D., Jenkins, B. J., et al. (2021) · Cancers · doi:10.3390/cancers13133224 · Cited by 19
Self-citationEasley, J. T., Maruyama, C. L., Wang, C.-S., & Baker, O. J. (2016) · Physiological Reports · doi:10.14814/phy2.12990 · Cited by 18
White, M. R., Hsieh, I.-N., Luna, X. D., & Hartshorn, K. L. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ab0220-116rr · Cited by 18
Hangui, L., Lin, X., Dan-mian, Y., Zhuang, Y., Wen, G.-F., Shi, J., & Sun, Y. (2017) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-017-4809-z · Cited by 17
Ortega, Á., Durán, P., Garrido, B., Manzano, A., Navarro, C., Silva, A., Rojas, M., Sanctis, J. B. D., Radzioch, D., Rivera-Porras, D., et al. (2025) · Molecules · doi:10.3390/molecules30102212 · Cited by 17
Audet, G. N., Dineen, S. M., Stewart, D. A., Plamper, M. L., Pathmasiri, W., McRitchie, S., Sumner, S., & Leon, L. R. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00242.2017 · Cited by 16
Yang, X., Li, R., Xu, L., Qian, F., & Sun, L. (2020) · Immunology and Cell Biology · doi:10.1111/imcb.12382 · Cited by 15
Repair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease
Deeb, R. S., & Hajjar, D. P. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.001 · Cited by 14
Kuret, T., Lakota, K., Mali, P., Čučnik, S., Praprotnik, S., Tomšič, M., & Sodin‐Šemrl, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195346 · Cited by 15
S100A12 Suppresses Pro-inflammatory, but Not Pro-Thrombotic Functions of Serum Amyloid A
Chung, Y. M., Goyette, J., Tedla, N. T., Hsu, K., & Geczy, C. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062372 · Cited by 14
Lipoxins as Modulators of Diseases
Saqib, U., Pandey, M., Vyas, A., Patidar, P., Hajela, S., Ali, A., Tiwari, M., Sarkar, S., Yadav, N., Patel, S. S., et al. (2025) · Cells · doi:10.3390/cells14161244 · Cited by 14
Single‐Cell Insights Into Macrophage Subtypes in Pulmonary Infections
Lin, Z., Zheng, Y., Zhong, Y., & Wang, H. (2026) · Advanced Science · doi:10.1002/advs.202510758 · Cited by 13
Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection
Colby, J. K., Gott, K., Wilder, J. A., & Levy, B. D. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0102oc · Cited by 12
Self-citationLee, K., Choi, J., Choi, B. K., Gu, Y.-M., Ryu, H. W., Oh, S.-R., & Lee, H.-J. (2019) · Molecules · doi:10.3390/molecules24102020 · Cited by 11
Finney, L., Mah, J., Duvall, M. G., Wiseman, D., Kamal, F., Fenwick, P. S., Ritchie, A. I., Kebadze, T., Orton, C. M., Bhavsar, P. K., et al. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202407-1325oc · Cited by 12
Self-citationAdvances in understanding COPD
Anderson, G. P. (2016) · F1000Research · doi:10.12688/f1000research.7018.1 · Cited by 15
Self-citationBaumann, K. K., Liang, W. S., Quaranta, D. V., Wilson, M., Asrat, H. S., Thysell, J. A., Sarchi, A. V., Banks, W. A., & Erickson, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021612 · Cited by 12
Novel Therapies for Pneumonia-Associated Severe Asthma Phenotypes
Papanicolaou, A., Wang, H., Satzke, C., Vlahos, R., Wilson, N. S., & Bozinovski, S. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.07.006 · Cited by 11
Self-citationZhou, Z., Fang, S., Liu, X., Li, C., Xie, Y., He, B., Sun, Q., Tian, T., Deng, X., & Fu, Q. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113081 · Cited by 11
Discovering Biomarkers of Neutrophilic Asthma: A Clinician’s Perspective
Kang, N., & Song, W. (2022) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2022.14.1.1 · Cited by 10
Interface between Resolvins and Efferocytosis in Health and Disease
Mohammad‐Rafiei, F., Negahdari, S., Tahershamsi, Z., & Hayat, S. M. G. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01187-4 · Cited by 8
Wang, W., Ren, W., Zhu, L., Hu, Y., & Ye, C. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112373 · Cited by 10
The lung-brain axis: elucidating the mechanisms of pulmonary-driven neurological disorders
Wang, L., Wang, F., Wang, X., Chen, X., Li, C., Shan, K., Zhou, H., Wu, G., Xu, Z., Kong, X., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03721-6 · Cited by 10
Serum amyloid A: multifaceted roles in inflammation and cellular interactions
Cheng, S., Duan, D., Cui, H., Lian, Y., Jiang, F., Chen, Q., Li, T., & Жао, Л. (2025) · Immunologic Research · doi:10.1007/s12026-025-09704-8 · Cited by 7
Lovins, H. B., Bathon, B. E., Shaikh, S. R., & Gowdy, K. M. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad100 · Cited by 7
ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation
Nunes, V. S., Abrahão, O., Rogério, A. D. P., & Serhan, C. N. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01787 · Cited by 9
Filep, J. G. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00063.2013 · Cited by 6
Hangui, L., Liu, H., Wang, K., Shi, J., & Sun, Y. (2021) · Ear Nose & Throat Journal · doi:10.1177/01455613211051311 · Cited by 5
cao, E., Xu, J., Gong, Y., Yuan, J., Chen, A., Liu, J., Fan, Y., Fan, X., & Kuang, X. (2023) · International Journal of COPD · doi:10.2147/copd.s395569 · Cited by 5
Serum Amyloid A and Immunomodulation
Fan, Y., Vong, C. T., & Ye, R. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81617 · Cited by 5
Lipidomic analysis reveals drug-induced lipoxin synthesis in glaucoma treatment
Mathew, D. J., Maurya, S., Ho, J., Livne‐Bar, I., Chan, D., Zhang, J. W., Buys, Y. M., Sit, M., Trope, G. E., Peters, D. M. P., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.192010 · Cited by 4
Mou, K., Chan, S. M. H., Brassington, K., Dobric, A., Luca, S. N. D., Seow, H. J., Selemidis, S., Bozinovski, S., & Vlahos, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.859146 · Cited by 3
Self-citationMaskey‐Warzęchowska, M., Rubinsztajn, R., Przybyłowski, T., Karwat, K., Nejman‐Gryz, P., Paplińska‐Goryca, M., & Chazan, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032478 · Cited by 3
Pereira, A. B. M., Gontijo, B. A., Tanaka, S. C. S. V., Vito, F. B. D., Moraes‐Souza, H., da Silva, P. R., & Rogério, A. D. P. (2025) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2025.106968 · Cited by 4
Keshtgarpour, M., Tan, W. S., Zwanziger, J., Awadalla, S., Langi, F. G., & Dudek, A. Z. (2016) · PubMed · Cited by 2
A soluble allergen sensor sounds the alarm
Hendriks, R. W. (2020) · Nature Immunology · doi:10.1038/s41590-020-0709-2 · Cited by 1
Dynamic changes of immune cells and therapeutic responses in experimental models of COPD
Xie, J., Li, P., Du, J., Li, S., Li, W., Zhang, J., Zeng, S., Zhang, Y., & Yong, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1698508 · Cited by 1
Lai, P. S., Hofmann, O., Baron, R. M., Cernadas, M., Meng, Q. R., Bresler, H. S., Brass, D. M., Yang, I. V., Schwartz, D. A., Christiani, D. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062910 · Cited by 1
Host Defense Peptides and the Eicosanoid Cascade
Wan, M., Tang, X. Y., & Haeggström, J. Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-32949-9_6 · Cited by 1
Theranostic drug delivery systems for targeted therapy of lung diseases
Katas, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820658-4.00019-4 · Cited by 2
Baumann, K. K., Liang, W. S., Quaranta, D. V., Wilson, M., Asrat, H. S., Thysell, J. A., Sarchi, A. V., Banks, W. A., & Erickson, M. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472859 · Cited by 1
Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma TreatmentPreprint
Mathew, M., Maurya, S., Ho, J., Livne‐Bar, I., Chan, D. W.-H., Buys, Y. M., Sit, M., Trope, G. E., Flanagan, J. G., Gronert, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.24.634771 · Cited by 1
La sérum amyloïde A, une des clés de la persistance de l’inflammation dans la BPCO ?
Monnier, D. (2012) · Option/Bio · doi:10.1016/s0992-5945(12)70999-6
Université de Poitiers Faculté de Médecine et Pharmacie
Couderc, E. (2014)
The Dynamics and Role of Neutrophils in an Elastase Model of Emphysema
Bradley, C. C. (2014)
Experimental studies of lipid mediator modulation of airway responsiveness
Abma, W. (2021) · Figshare
Gouveia, G. C., de Sousa, H. I., Salermo, B. S., Pereira, A. B. M., da Silva, P. R., dos Santos, W. M., Uddin, M., Levy, B. D., & Rogério, A. D. P. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4066175
Self-citationZhou, Y., Zhong, X., Chen, Y., Xia, H., Zhao, M., Zhao, M., Xu, L., Song, P., Qi, X., Jiang, C., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4123176
Vietri, L. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009474
Serum amyloid A and its clinical significance
Vilímová, K., Michnová, O., & Kušnierová, P. (2022) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2022.023
Wang, Y., Bao, Y., Liu, B., Li, H., Duan, H., Wang, Y., Zhang, J., Wu, W., Li, P., & Liu, X. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s556221 · Cited by 1
Li, X., Xu, H. M., Shi, M., Liu, K., & Liu, X. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117772
Molecular and cellular bases of monogenic auto-inflammatory diseases and AA amyloidosis
Jumeau, C. (2019) · theses.fr (ABES) · doi:10.70675/73c2c7f0z679dz44b8z8b68zb2fce75a3d70
Steinmetz, L.-K., Seeliger, B., Schupp, J. C., Bormann, T., Aschenbrenner, F., Maus, R., DeLuca, D. S., Gaedcke, S., Pich, A., Knudsen, L., et al. (2026) · ERJ Open Research · doi:10.1183/23120541.01320-2025
Millar, B., Godson, C., & de Gaetano, M. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_367
Metadata
- Authors
- Bozinovski, S., Uddin, M., Vlahos, R., Thompson, M., McQualter, J. L., Merritt, A.-S., Wark, P. A. B., Hutchinson, A., Irving, L. B., Levy, B. D., & Anderson, G. P.
- Affiliations
- The University of Melbourne (AU)
- Brigham and Women's Hospital (US)
- Department of Pharmacology, and
- The Royal Melbourne Hospital (AU)
- John Hunter Hospital (AU)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-01-03
- Volume
- 109
- Issue
- 3
- Pages
- 935-940
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3271884
- OpenAlex
- W1969944763
- Cited by
- 163
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 4 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 11 · 2016: 12 · 2015: 11 · 2014: 12 · 2013: 21 · 2012: 7
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Figshare (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL090927, HL-68669, P50HL107166, HL090927, R01HL068669)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- serum amyloid A, lipoxin A4, chronic obstructive pulmonary disease, glucocorticoid resistance, lung inflammation, neutrophil recruitment, airway epithelial cells, interleukin-8, neutrophil elastase, acute exacerbation, lung macrophages, bronchoalveolar lavage fluid
- MeSH terms
- Serum Amyloid A Protein, Animals, Bronchoalveolar Lavage Fluid, Epithelial Cells, Epithelium, Glucocorticoids, Humans, Lung, Macrophages, Mucous Membrane, Neutrophils, Pneumonia, Interleukin-8, Neutrophil Activation, Pulmonary Disease, Chronic Obstructive, Receptors, Formyl Peptide, Lipoxins, Receptors, Lipoxin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
